Vetoshkina T V, Fomina T I
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
Bull Exp Biol Med. 2003 Jan;135 Suppl 7:85-7. doi: 10.1023/a:1024747200854.
Ultralow doses of antibodies to phenobarbital and their mixture (1:1) with ultralow doses of antibodies to cholecystokinin reduced the severity of structural and metabolic disturbances in the liver of rats with acute CCl4-induced hepatitis. The mixture of antibodies had no effect on the course of CCl4-induced hepatitis.
超低剂量的苯巴比妥抗体及其与超低剂量胆囊收缩素抗体的混合物（1:1）减轻了急性四氯化碳诱导性肝炎大鼠肝脏结构和代谢紊乱的严重程度。抗体混合物对四氯化碳诱导性肝炎的病程没有影响。
